Showing results (161-170 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|June 18, 2005
Remission from depression : a review of venlafaxine clinical and economic evidenceDonald Han, Edward C Y WangPharmacoeconomics|June 29, 2006
Economic models of antiretroviral therapy: searching for the optimal strategyFred J HellingerPharmacoeconomics|June 29, 2006
Developing health-related quality-of-life instruments for use in Asia: the issuesYin Bun Cheung, Julian ThumbooPharmacoeconomics|June 29, 2006
Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapiesJohn B WongPharmacoeconomics|June 10, 2006
Is the childhood asthma questionnaire a good measure of health-related quality of life of asthmatic children in Asia?: validation among paediatric patients with asthma in SingaporeLee-Yee Chong, Oh-Moh Chay, Li Shu-ChuenPharmacoeconomics|September 13, 2005
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infectionsGreg L Plosker, David P FiggittPharmacoeconomics|June 30, 2022
Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe ObesityBjörn Schwander, Klaus Kaier, Mickaël Hiligsmann, et al.Pharmacoeconomics|November 26, 2022
The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons LearnedSahar Al Shabasy, Bram Roudijk, Maggie Abbassi, et al.Pharmacoeconomics|December 18, 2022
Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature ReviewFiammetta M Bozzani, Fern Terris-Prestholt, Matthew Quaife, et al.Pharmacoeconomics|January 19, 2023
Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer TreatmentYuqiong Lu, Zhanjing Dai, Feng Chang, et al.Pageof 335